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Abstract 
Uterine fibroids have always been the prime medical issue for females, especially the ones travelling in their 
reproductive age ( 20-35), with some studies reporting 20-80% of women developing fibroids by the  age of  50 
also. Apart from being of reproductive age there are other risk factors to be familiar with, which includes race, 
obesity, heredity and hypertension. Fewer than 25% of patients with fibroids have symptoms but those 
experiencing them have to compromise with the quality of life. Despite of extensive research actual cause of 
these tumors remains unrevealed, that restrains for  an effective pharmaceutical approach. According to latest 
research environment alone or in interaction with genetic factors influence the formation and growth of uterine 
fibroids. An awareness of such factors can lead to more advance non–invasive treatment for such deep  uterus 
monsters. 
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1. Introduction 
Reproduction phase of women is accompanied by various gynecological disorders, that seriously affects the  
quality of life .One most frequent among them is a  genetically or hormonally induced and regulated  tumor 
known by different names such as as leiomyoma’s, myoma, leimyomata, fibromyoma or uterine fibroids. These 
are clonal neoplasm of uterus that have both smooth muscle and fibroblast components, in addition to 
substantial amount of fibrous extracellular matrix that contribute to pathogenic process. The discovery of these 
lesions lays back to Hippocratic period in 460-375 B.C, when they were called “uterine stone”, later, in 
Christian period it was called “scleromas” by Galen. The term fibroid was coined and introduced in 1860 by 
Rokitansky and in the 1863 by Klob, while word “myoma” was given by a German pathologist named Virchow 
in 1854 [1].                      
They are extremely heterogeneous in their pathophysiology, size, location and clinical symptomatology. One of 
the most surprising fact about such myomas is that black women have a higher risk of encountering these 
fibroids earlier in life with more severe symptoms  than their white counterparts, clinically they account for one-
third to half  of all hysterectomies in US,  recently some authors have  reported a statistically significant inverse 
correlation between serum 25-(OH) Vitamin D levels and fibroid prevalence in black subjects [2]. The 
pathogenesis of fibroids seems to involve a positive feedback loop between extracellular matrix production and 
cell proliferation, and vitamin D might act to block the positive feedback  . It is also seen that women after the 
age of 30 are more likely to develop symptoms may be due to time-related hormonal changes or an enhanced 
symptomatology from already existing fibroids.  Exact biology behind there occurrence is still unknown, but 
there are several distinct pathways involved in leiomyomata formation. Human uterus can increase its capacity 
from 500- to 1000-fold and increase its weight more than 20-fold during pregnancy and then retains its original 
size. This remodeling of uterus indicates the presence of adult stem/progenitor cells that reside in myometrial 
compartments [3]. We suspect that several pathological conditions, such as endometrial cancer, adenomyosis, 
and leiomyoma, can be attributed to dysregulation of these stem cells. Recent studies also suggest the 
involvement of epigenetic mechanisms such as DNA methylation and micro-RNA and histone modification in 
leiomyomas [4]. The cellular origin of uterine leiomyomas remains undefined but it is believed that the 
transformation of a single tissue-specific stem cell within the myometrium can be an important factor. Stem 
cells derived from leiomyoma tissues are known to carry MED12 mutations, This finding suggests that at least 
one genetic hit initially transforms a myometrial stem cell that subsequently interacts with the surrounding 
myometrial tissue to give rise to a leiomyoma tumor [3].  Step towards such findings also have developed the 
idea that Genetic factors likely influence fimbroid development and growth; approximately 40% of uterine 
leiomyoma have chromosomal abnormalities detectable by conventional cytogenetic analysis like several 
mutations, such as germ line mutations causing fumarate hydratase deficiency, have been associated with 
leiomyoma formation ,also aberrations involving the short arm of chromosome 6 or the long arm of 
chromosome 12. Two members of the high-mobility group (HMG) protein gene family, HMGIC and HMGIY, 
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are found to be frequently rearranged in  tumors and  it has been suggested that these genes are directly involved 
in the aberrant growth control observed in tumors[5]. Recurrent somatic mutations in MED12 was  also 
identified as  most frequently altered gene in leiomyoma’s. A striking feature of  uterine fibroids is their 
dependency on the ovarian Steroids estrogen and progesterone and their ligands. These hormones initiates the 
growth of these uterine fibroids. Estrogen/progesterone treatment of mature myometrial cells induces expression 
of WNT11 and WNT16, which remained constitutively elevated in leiomyoma tissues and also  targets nuclear 
translocation of β-catenin and induced transcriptional activity of its heterodimeric partner T-cell factor and their 
target gene AXIN2, leading to the proliferation of these  cells. This effect could be blocked by a WNT 
antagonist. Several growth factors, such as vascular endothelial growth factor (VEGF), EGF, heparin binding 
epidermal growth factor (HB-EGF), PDGF, IGF, TGF-α, TGF-β, acidic fibroblast growth factor (aFGF), and 
basic fibroblast growth factor (bFGF), and their respective receptors have been demonstrated to play a role in 
leiomyoma growth [6]. 
Depending on their position fibroids can be of four types : intramural, subserosal, sub mucosal and 
pedunculated. A woman may have one or all of these types of fibroids. Some fibroid tumors don’t produce any 
symptoms at all, while others can be severely symptomatic. It is common for a woman to have multiple fibroid 
tumors also. INTRAMURAL fibroids are the most common type of tumors that develop within uterine wall and 
extend from there and can cause bulk of symptoms, which include excessive menstrual bleeding that may cause 
prolonged menstrual cycles and clot passing, and pelvic pain that is caused by the additional pressure placed on 
surrounding organs by the growth of the fibroid. If developed in the cervical region it can prevent the entry of 
the sperm into the uterus [7]. 
Developing on outer uterine wall SUBSEROSAL tumors exerts additional pressure on surrounding organs . 
Symptoms of subserosal fibroid tumors usually do not include abnormal or excessive menstrual bleeding or 
interfere with a women’s typical menstrual flow. These fibroid tumors instead cause pelvic pain and pressure. 
Depending on the severity and the location of the fibroids other complications can accompany this pain and 
pressure [7]. 
 The least common and most complicated is the SUBMUCOSAL fibroids that develop just under the lining of 
the uterine cavity. Large submucosal fibroid tumors may increase the size of the uterus cavity, and can block the 
fallopian tubes preventing ovum release and sperm from entering which can cause complications with fertility. 
Myomas greater than 5 cm in size, or located near the Ostia of the fallopian tubes, are more likely to cause 
fertility problems. Other associated symptoms with submucosal fibroids include very heavy, excessive 
menstrual bleeding and prolonged menstruation. These symptoms can also cause the passing of clots, and 
frequent soiling which can take its toll on your everyday lifestyle. Untreated, prolonged or excessive bleeding 
can cause more complicated problems such as anemia and/or fatigue, which could potentially lead to a future 
need for blood transfusions [7].  
PEDUNCULATED uterine fibroids occur when a fibroid tumor grows on a stalk, resulting in pedunculated 
submucosal or subserosal fibroids. These fibroids can grow into the uterus and also can grow on the outside of 
the uterine wall. Symptoms associated with pedunculated fibroid tumors include pain and pressure as the 
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fibroids can sometimes twist on the stalk. Some fibroid tumors don’t produce any symptoms at all, while others 
can be severely symptomatic [7]. 
Certain general symptoms include pain in legs that is due to fibroids press on nerves that extend to the pelvis 
and legs, pressure on bladder that can cause frequent urination, urinary incontinence or urine retention, pressure 
on bowl that leads to constipation and/or bloating. The constipation may be exacerbated by iron supplements 
taken for the anemia caused by excessive bleeding, lower back pain, Infertility, recurrent miscarriage or 
premature labor during pregnancy. Growth of fibroids during pregnancy complicates the condition mainly due 
to the flux of steroid hormones. Normally the myomas are not removed during pregnancy due to the increased 
risk of hemorrhage. It is possible that between weeks 12-22 the blood supply to the fibroid may stop causing it 
to turn red and die, this is called “Red Degeneration”, which is accompanied by intense abdominal pains and 
contractions that becomes a cause of premature labor or even miscarriage [8]. An important fact has come into 
light that women with fibroids are not more prone to fibrocystic changes in the breast, a totally unrelated 
condition and they are not more prone to develop any other benign or cancerous conditions.  
Fibroids are an enormous healthcare problem because they are the primary reason given for surgery in 199,000 
hysterectomies and 30,000 myomectomies performed yearly in the US .The medical treatments readily available 
for fibroids can range from mild to severe, leaving women of childbearing age unable to have children [9]. 
Currently there are limited therapies and no prevention strategies available, this paper clarifies the natural 
history of uterine fibroids involving environmental and lifestyle influence on endocrine function and other 
epidemiological factors. 
 It is likely that factors in the environment acting alone or in interaction with genetic factors influence the 
formation and growth of uterine fibroids. Medical studies have shown that diet, smoking and various types of 
contraception affect the risk of developing fibroids. There has also been research into chemicals which women 
are exposed to and whether these chemicals can cause fibroids to form and grow. Another possibility is that 
current environmental factors may cause genes which have been dormant in previous generations to exert their 
influence. Scientists and doctors are concerned about chemicals such as pesticides or toxins which have an 
estrogen-like affect. 
1.a    Synthetic chemicals 
A number of studies have evaluated exposure to environmental endocrine disruptors, such as diethylstilbestrol 
(mixed), phenols (null), dioxin (protective), and polychlorinated biphenyls (increased) . The danger of estrogen-
like chemicals already has been well-documented with DES, or diethylstilbestrol, a drug that was prescribed to 
millions of women at risk of miscarriages from 1940 through 1971. Daughters and granddaughters of the 
pregnant women who took the potent estrogenic drug had an increased risk of endometriosis, uterine fibroids 
and rare reproductive cancers. Also the intake of xenoestrogens, or environmental chemicals that possess 
estrogenic activity fuels  fibroid growth, such as bisphenol A in water bottles and canned foods [10]. 
1.b  Dairy/ diet 
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Research has suggested a relationship may exist between diet and the growth of uterine fibroids. More than a 
decade ago, a study by Chiaffarino and colleagues published in Obstetrics & Gynecology reported that uterine 
fibroids were associated with the consumption of ham and beef. The study indicated that a high intake of green 
vegetables has a protective effect against fibroids “Italian women with fibroids have been observed to consume 
more red meat and ham, and alcohol consumption has been linked to increased likelihood of fibroids in Japanese 
women [11]. In the study, published in the January 2010 issue of the American Journal of Epidemiology, 
researchers followed more than 22,000 premenopausal black women from the US Black Women’s Health Study 
over a 10-year period. Results based on dietary intake were used to assess whether intake of dairy foods such as 
low-fat and whole milk, cheese, yogurt, and ice cream—and some dairy components such as calcium, vitamin 
D, and butyric acid—may reduce risk of uterine fibroids. The findings indicated a lower risk of uterine fibroids 
associated with higher dairy consumption. The perceived protective effect of dairy, according to the researchers, 
may lie in the ability of calcium to reduce fat-induced cell proliferation and in butyric acid (present in milk fat), 
which is considered a potent antitumorigenic agent that may inhibit cell proliferation and angiogenesis [12]. 
That can be  an expected reason for black women to suffer more , which consumes less dairy products (and thus 
have lower mean intakes of calcium, magnesium, and phosphorus) than whites. Eating foods with a high dietary 
glycemic index (GI), a measurement of the effects of carbohydrates on blood glucose levels, or high glycemic 
load (GL), a ranking of carbohydrate content of various foods based on their GI, is thought to potentially 
promote tumor growth by increasing endogenous concentrations of insulin like growth factor 1 (IGF-1). 
Examples of high GI and GL foods include instant white rice, white bread, rice cakes, French fries, donuts, and 
scones. In vitro studies have shown that uterine fibroid cells proliferate in the presence of IGF-1. Other studies 
have found a positive association between high GL and other hormone-responsive tumors, such as ovarian and 
endometrial cancer. Radin and colleagues have mentioned in a study published in the May 2010 issue of the 
American Journal of Clinical Nutrition that a high GI and GL diet may encourage uterine fibroid growth, they 
concluded that high dietary GI (but not GL) may be associated with increased uterine fibroid risk overall, and 
high GL was associated with increased risk in women younger than 35 [13]. 
Soybeans are a rich source of phytoestrogens, specifically isoflavones, that may have an “antiestrogen” effect in 
the body by competing with estrogen for receptor binding, thereby possibly decreasing the availability of 
estrogen or altering estrogen biosynthesis. In the January issue of Experimental and Molecular Medicine, Di and 
colleagues reported that high serum concentrations of genistein (an isoflavone abundant in soybeans) 
downregulate several signaling pathway genes involved in uterine fibroid growth, suggesting that high doses of 
this isoflavone have an inhibitory effect on uterine fibroids and therefore a potential to be used as a therapeutic 
agent in their treatment [13] but Converse to this, in  May 2009 issue of the British Journal of Nutrition, Nagata 
and colleagues said they observed no statistically significant association between soy isoflavones and uterine 
fibroids in 285 premenopausal Japanese women [13]. 
In the January 2011 issue of Fertility and Sterility, Sharan and colleagues reported that vitamin D inhibits the 
growth of cells involved in uterine fibroid growth, suggesting that low serum vitamin D levels may be a risk 
factor for their development. In the December 2011 issue of the American Journal of Clinical Nutrition, relation 
between dietary intake of fruits, vegetables, and carotenoids, and fibroid risk was discussed. It was observed that 
there is a reduced risk of uterine fibroids among women with greater intake of fruit and retinol, preformed 
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vitamin A from animal sources such as whole milk and eggs as well as reducing the intake of growth hormones 
present in foods such as conventionally raised, nonorganic beef reduces the risk. Foods such as white bread, 
cookies, cakes, and pasta increase insulin, which changes the way estrogen is metabolized, creating compounds 
that are more likely to cause cellular inflammation and fibroid symptoms, including enhanced growth of existing 
fibroids[14]. women with fibroids should  increase their intake of cruciferous vegetables such as cabbage, 
broccoli, and kale. This group of vegetables, in particular, contains indole-3-carbinol, according to  research 
which may prevent estrogen-driven tumors due to its effect on estrogen metabolism [15]. 
chemicals like caffeine and alcohol also  put stress on the liver, making it work less effectively at metabolizing 
estrogen in the body. Specific food groups and nutrients can also  help women manage fibroids by encouraging 
weight loss, because estrogen is also produced in peripheral fat in the form of estrone, which  in higher doses 
such as in overweight women, affect fibroid growth and cause them to be more symptomatic. The dietary 
component towards the treatment of fibroids can add to the traditional therapies to treat this condition [16]. 
1.c   Herbal products 
There are various herbal products as well that can help reduce the risk of fibroids like:  
VITEX- helps to normalize hormonal production and ovulation through its effects  on the pituitary gland   
DANDELION- is a very good nutritive herb with high levels of vitamins and minerals and  improves liver 
function, helping to metabolize hormones.   
WITCH HAZEL- is  a good astringent herb to help with excessive uterine bleeding  
WILD YAM-a good antispasmodic (Pain reliever) 
CRAMP BARK- is used for relieving cramps, including muscle spasms, menstrual cramps, and cramps during 
pregnancy and also used as a kidney stimulant for urinary conditions that involve pain or spasms. 
BLACK HAW- is used for relieving cramps after pregnancy and for treating miscarriage 
Method 1 : complications of leiomyomas during caesarian section: a case report. 
We analyzed 20 women (aged between 30-40 years) that were in their  12-15 weeks of  pregnancy. 
 The study  was conducted in Kanpur dehat (suburbs of Kanpur), and 6 were screened among them that were 
recommended c- section by their gynecologists. Inconsistent increase in their abdomen size was reported as 
discussed by their gynecologist  and  sonography reports  revealed large intramural, subserosal or pedunculated  
fibroids (ranging between 10.5-13 cm) on the anterior wall of the maternal uterus encroaching upon the cervix, 
along with their  fetus.  
The patients  were examined and were   admitted  due to pain reported in the above data .  Detailed sonographic  
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images of the fetus at 20 weeks of gestational  period  showed no evidence of any major structural abnormalities 
but later on the size of these myomas  was seen to increase  progressively. 
Table 1: complications of leiomyomas during caesarian section: a case report . 
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1. 32 yr. 70 kg. 12 week Intramural 
Fibroid  
12 cm Present  in 
mother 
Pain due to red 
degeneration 
  10.2g/dl 
 
 
2. 30 yr. 75 kg. 13.5 weeks pedunculat
ed fibroid 
11.3 cm Effected sister Bleeding during 
initial stage of 
pregnancy 
   9.5 g/dl 
3. 35 yr. 80 kg. 15.3 weeks Intramural, 
near cervix 
10.8 cm No report Pain due to 
fibroid 
degeneration 
  10.5 g/dl 
4. 29 yr. 84 kg. 14 weeks Subserosal 
, 
encroachin
g cervix   
11.5 cm Present  Pain due to red 
degeneration 
  10.9 g/dl 
5. 33 yr. 79 kg. 12.5 weeks Intramural, 
blocking 
birth canal 
  13 cm Not present Hypertension, 
retarded fetal 
growth  
  10.2 g/dl 
6. 36 yr.  88 kg. 15 weeks Subserosal, 
in the 
lower 
uterus 
12.4 cm No report Pain, enlarged 
uterus 
   9.9 g/dl 
 
Their last ultrasonography reports as discussed by  the gynecologist  showed  fibroids reaching unto 25-30 cm. 
Myomectomy was preformed after  delivery. 
The babies were  healthy and the patients were discharged after 7-8 days [16] . 
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Method- b 
Surgical removal of uterus is the only choice for fibroids : case study 
Table 2: Surgical removal of uterus is the only choice for fibroids: case study 
Case no. Age Position of 
fibroid 
Size of myomas    Hb reading  Other 
symptoms 
No. of 
miscarriages 
1. 44 yr.   Submucosal, 
in               
endometrium  
        4.5 kg      9.8 g/dl Long and 
heavy          
bleeding 
         4 
2. 42 yr.   sub mucosal         3.4 kg       9.2 g/dl Prolonged 
bleeding 
          3 
3. 48 yr. pedunculated          3.3 kg        8.8 g/dl Abnormal 
vaginal bleeding 
          4 
4. 45 yr.  Subserosal             2.4 kg        8.3 g/dl Heavy   
prolonged 
bleeding 
           3 
5. 42 yr. intramural            4.5 kg.       8.2 g/dl Abnormal 
vaginal bleeding 
            3 
 
8 cases( near the age of menopause , 40-48)  were reported in the gynecology department of city hospital in 
Kanpur Nagar. The patients reported  problem of heavy  and prolonged bleeding. 
There clinical reports, as discussed by their doctor  also indicated the history of mass per abdomen and 
miscarriages. The best way to get rid of fibroid complications in most of the cases (5)  was to remove the uterus 
along with the fibroids( total hysterectomy) [17].  
Method-3 
Laparoscopic Myomectomy for Multiple Submucous Myomas: case report 
A study was carried out on 5 women ( aged between 28- 35 yr.) with multiple submucous fibroids that were all 
above 5 cm. 
 Clinical diagnosis of the patients revealed their uterine mass above 16 weeks. As discussed by their 
gynecologist, they also have a history of abnormal uterine bleeding due to which their hemoglobin level was 
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also at risk level (between 5.5-7 g.%).  
Ultrasonography reports indicated enlarged uterus with multiple echoes in endometrial lining. The safe measure 
to avoid them from perforation and fluid overload that can occur during normal hysterectomy, laparoscopic 
myomectomy was suggested [18]. 
Table 3: Laparoscopic Myomectomy for Multiple Submucous Myomas: case report 
 
Method-4 
Unusual presentation of rare uterine leiomyosarcoma: case study 
Uterine leiomyosarcoma is a rare form of uterine cancer that occurs mainly in women after menopause . 4 
women aged between 40- 50 years were screened from urban areas of  Kanpur nagar.  
Their clinical reports as discussed by the gynecologist showed pelvic mass growth, and uterine size increased 
upto 20 weeks, also they complained about symptoms including lower abdominal pain, pelvic pressure etc. 
Increased rate of CA-125 level ( normal- : 0-35 ng/ml) also indicated the malignant tumor[19].  
Case no.   Age Type of fibroid Size of 
fibroid 
Uterine 
mass 
Hb reading symptoms No. of fibroids 
removed 
1. 30 yr. Multiple submucous All above 
7 cm 
20 weeks    6.7 gm.% Abnormal 
uterine 
bleeding 
             58 
2. 33 yr. Multiple submucous All above 
6 cm 
16 weeks   5.7 gm.% Heavy and 
prolonged 
bleeding 
             54 
3. 28 yr. Multiple submucous  All above 
5.9 cm 
18.5 weeks    6.9 gm.% Abnormal 
vaginal and 
uterine 
bleeding 
              60 
4. 29 yr. Multiple submucous All above 
5 cm 
21 weeks     6.8 gm.%  Uterine 
cramps and 
heavy 
bleeding 
              65 
5. 32 yr.  Multiple submucous All above 
6.6 cm 
22 weeks       5.9 gm.% menorrhagia         58 
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Table 4: Unusual presentation of rare uterine leiomyosarcoma: case study 
Case no.   Age                     Symptoms                          Stage                                                  
1. 46 yr. Lower abdominal pain, mass arising 
from pelvis, uterus enlarged to 17 weeks, 
increased CA-125 level  
                           1 
2. 48 yr. Mass arising from pelvis, pelvic 
pressure, uterus enlarged to 20 weeks , 
inc. CA-125 level. 
                            1  
3. 49 yr. Pelvic mass, swelling , weight loss, post 
menstrual bleeding 
                            2 
4. 46 yr.    Pelvic mass, lower abdominal pain, 
uterus enlarged to 16 weeks 
                                  2                           
        
3. Conclusion 
Constant regular menstrual cycles have played a role in the formation of uterine fibroids as well as other 
gynecological diseases. Fibroids are constantly being remodelled as certain genes are turned on and others are 
turned off each month as a result of the changing hormonal levels of estrogen and progesterone during the 
normal menstrual cycle. One theory states that having, on average, 13 menstrual cycles every year for up to 40 
years gives room for many mistakes to take place within the tissues of the uterus. Thus, genetic or 
environmental factors plus having regular menstrual periods may be the initial problem and uterine fibroids are 
the resulting endpoint of the tissue damage which occurs because of these factors, also modern women have less 
pregnancies which  may lead to an increase in fibroids that grow and are diagnosed. Because the only approach 
towards successful treatment was surgical strategies including  myomectomy or hysterectomy, also new 
techniques are on the fast way towards treatment but it is believed that   etiological clues in factors including 
dietary, stress, and environmental influences will enhance the work. 
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